Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Belimumab + Rituximab for Systemic Sclerosis
Recruiting0 awardsPhase 2
New York, New York
This trial will test whether a combination of Belimumab & Rituximab, given on top of standard Mycophenolate Mofetil therapy, can improve fibrosis in early diffuse cutaneous systemic sclerosis (dcSSc) patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.